Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine infusion versus prednisolone for medication overuse headache
IRCT20141023019640N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ketamine and prednisolone in medication overuse headache (MOH) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Severity of headache and Frequency of headache. Started Jun 2024; status: completed.
02
Drugs
ketamineprednisolone
03
Conditions
medication overuse headache (MOH)
Beyond the preview
Go deeper on IRCT20141023019640N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141023019640N3.